Become a Member
  • Track your favourite stocks
  • Create & monitor portfolios
  • Daily portfolio value
Sign Up
Quickpicks
Add shares to your
quickpicks to
display them here!

Hikma Pharmaceuticals (HIK)

Price 1,837.00p on 21-11-2024 at 09:34:27
Change -8.00p -0.43%
Buy 1,838.00p
Sell 1,836.00p
Buy / Sell HIK Shares
Last Trade: Buy 162.00 at 1,837.00p
Day's Volume: 18,809
Last Close: 1,845.00p
Open: 1,847.00p
ISIN: GB00B0LCW083
Day's Range 1,821.00p - 1,847.00p
52wk Range: 1,711.00p - 2,165.00p
Market Capitalisation: £4,076m
VWAP: 1,840.99124p
Shares in Issue: 222m

Recent Trades History Hikma Pharmaceuticals (HIK)

Buy/Sell Volume Trade Prc Trade Type Trade Time
Buy* 162 1,837.00p Automatic Execution
09:31:18 - 21-Nov-24
Buy* 107 1,836.00p Automatic Execution
09:30:13 - 21-Nov-24
Buy* 45 1,836.00p Automatic Execution
09:30:13 - 21-Nov-24
Buy* 48 1,838.00p Automatic Execution
09:28:47 - 21-Nov-24
Buy* 246 1,836.00p Automatic Execution
09:27:33 - 21-Nov-24
Buy* 327 1,836.00p Automatic Execution
09:27:33 - 21-Nov-24
Buy* 150 1,836.00p Automatic Execution
09:27:33 - 21-Nov-24
Buy* 28 1,836.00p Automatic Execution
09:27:33 - 21-Nov-24
Buy* 14 1,836.00p Automatic Execution
09:27:33 - 21-Nov-24
Sell* 1 1,843.00p Automatic Execution
09:08:39 - 21-Nov-24

Share Price History for Hikma Pharmaceuticals

Time period:
to
Date Open High Low Close Volume

Share News for Hikma Pharmaceuticals

Hikma Pharmaceuticals reiterates full-year guidance amid strong growth

7th Nov 2024 10:59

(Alliance News) - Hikma Pharmaceuticals PLC on Thursday said it is on track to deliver "another strong performance" following trading to date, and reiterates its full-year revenue expectations. Read More

UK earnings, trading statements calendar - next 7 days

31st Oct 2024 14:52

Read More

UK dividends calendar - next 7 days

13th Sep 2024 12:38

Read More

Hikma Pharmaceuticals completes acquisition of Xellia's FDF business

10th Sep 2024 09:09

(Alliance News) - Hikma Pharmaceuticals PLC announced on Tuesday it has completed its acquisition of the US finished dosage form business. Denmark-based Xellia Pharmaceuticals ApS. Read More

LONDON BROKER RATINGS: Berenberg raises Hikma Pharmaceuticals to 'buy'

3rd Sep 2024 09:43

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and on Monday: Read More

FTSE 100 Latest
Value8,070.46
Change-14.61

Login to your account

Forgot Password?

Not Registered